SlideShare uma empresa Scribd logo
1 de 19
Baixar para ler offline
BIBioTech
BI
Applying
Validation
A case stu
Stage 1 –
TECH
LOGIC
BioTechLogic, Inc.
BIO TECH
LOGICBIO ®
TECH
IOLOGIC
Logic, Inc.
IO ®
g QbD to Biotech Process
n :
udy in applying QbD to
– Process Design
IVT Validation Week
28-30 March 201128 30 March 2011
Kurtis Epp, John Kandl
BioTechLogic, Inc.
Agenda
• Process Backgrou
• Risk Assessment
• DOE
• Parameter Evaluat
• Conclusions
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
und
tion
Slide 2
Company Confidential
Process Back
The scope of this case stup
data obtained from small-
Chromatography runs per
limits in experiments planlimits in experiments plan
Design of Experiments (D
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
kground
udy is to provide and evaluatey p
-scale Ion Exchange
rformed within defined parameter
ned and executed according toned and executed according to
DOE).
Slide 3
Company Confidential
Process Back
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
kground
Slide 4
Company Confidential
Risk Assessm
Operating Parameter Normal Operating
UV at Start of AEX Fraction Collection > 0.50 AU
UV at End of AEX Fraction Collection < 20% of maximum p
Elution Gradient
8% per CV
Elution Gradient
(20 – 100% B ove
Equilibration volume ≥ 5 CV
Load flow rate 100 – 120 L/h (Targe
Wash flow rate 100 – 120 L/h (Targe
Elution flow rate 100 – 120 L/h (Targe
Pre-Equilibration flow rate 100 – 120 L/h (Targe
F1 F3: 0 2
Fraction Volume
F1 – F3: 0.2
F4+: 0.1 CV
Wash volume ≥2 CV
Fraction Mixing Speed 65 rpm
Fraction Mixing Time 20 - 30 min
Pool Mixing Time
10 – 15 min
Pool Mixing Time
Pool Mixing Speed
100 rpm
Pre-Equilibration volume ≥ 4 CV
WFI Rinse volume ≥ 3 CV
WFI Rinse flow rate 100 – 120 L/h (Targe
Equilibration flow rate 100 – 120 L/h (Targeq ( g
In-Process Control Limits
Column Load 15 – 25 g / L r
Column Bed Height 30 ± 3 cm
Column Backpressure during
Equilibration, Load, Wash, and Elution
< 3 bar
Effl t H t d f E ilib ti
± 0.3 pH Units of Eq
Effluent pH at end of Equilibration
p q
Buffer pH
Effluent Cond. at end of Equilibration
± 1 mS/cm Units of E
Buffer Conduc
Effluent UV at the end of Equilibration Zero
Fraction Pooling Criteria (RP-HPLC) ≥ 95% Main P
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
ment
g Range Potential Effect(s) of Failure SEV OCC DET RPN
U Product loss, quality 9 4 2 72
peak height Product loss, quality 9 4 2 72
V
Inconsistent quality 8 2 4 64
r 10 CV)
Inconsistent quality 8 2 4 64
Product loss, quality 9 2 1 18
et: 110 L/h) Inconsistent quality 4 1 3 12
et: 110 L/h) Inconsistent quality 4 1 3 12
et: 110 L/h) Inconsistent quality 4 1 3 12
et: 110 L/h) Longer equilibration 4 1 3 12
CVCV
V
Product loss, quality 9 1 1 9
Inconsistent quality 5 1 1 5
Inconsistent quality 4 1 1 4
n Inconsistent quality 4 1 1 4
n
Non-homogeneity, inconsistent
sampling/yield
4 1 1 4
sampling/yield
Non-homogeneity, inconsistent
sampling/yield
4 1 1 4
Longer equilibration 3 1 1 3
Longer equilibration 3 1 1 3
et: 110 L/h) Longer equilibration 1 1 1 3
et: 110 L/h) Product loss, quality 3 1 1 3) , q y
resin
m
quilibrationq
Equilibration
ctivity
Peak
Slide 5
Company Confidential
Risk Assessm
The parameters selectedp
the UV at start of fraction
collection, gradient slope
D d t i blDependent variables ana
and purity by RP-HPLC.
Testin
Input parameter
Lower
UV at the beginning of
fraction collection (AU)
0.40
UV at the end of pooling
(% from peak max)
10
Gradient slope (% per CV) 4.0
Resin Load, (g/L resin) 15
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
ment
d for evaluation in this study werey
n collection, UV at end of fraction
e, and resin load.
l d t i i ldalyzed were protein recovery yield
ng limitsg
Output parameters
Upper
0.60
Purity by RP-HPLC (≥ 95%)
Step yield (≥ 75%)
30
12.0
25
Slide 6
Company Confidential
DOE
Pattern Exp. No.:
UV at the sta
of fraction
collection
p
collection
(AU)
−−−− 1 0.4
0000 2 0.5
0000 3 0 50000 3 0.5
−++− 4 0.4
0000 5 0.5
++−− 6 0.6
7 0 6+−−+ 7 0.6
++++ 8 0.6
+−+− 9 0.6
−−++ 10 0.4
0000 11 0.5
−+−+ 12 0.4
Note: It is important to randomize
independence of your observation
mistake by the operator.
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
art
n
UV at the end
of pooling
Gradient
slope
Resin Load
(g/L)
(% peak max) (% per CV)
(g/L)
10 4 15
20 8 20
20 8 2020 8 20
30 12 15
20 8 20
30 4 15
10 4 2510 4 25
30 12 25
10 12 15
10 12 25
20 8 20
30 4 25
e the run order to assure the
ns and reduce the chances of a
Slide 7
Company Confidential
Experimental
• A summary of the var
Ion Exchange Chrom
Outputs step yield anOutputs, step yield an
listed in the following
• Runs that did not mee
are shaded to indicate
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
Results
riable parameters for each of the
atography runs as well as the
nd eluate purity by RP HPLC arend eluate purity by RP-HPLC are
table.
et the defined acceptance criteriap
e run failure
Slide 8
Company Confidential
Experimental
Run Resin Load GradientRun
Number
Resin Load
(g/L)
Gradient
Slope (%)
1 15 4
2 20 8
3 20 8
4 15 12
5 20 85 20 8
6 15 4
7 25 4
8 25 128 25 12
9 15 12
10 25 12
11 20 811 20 8
12 25 4
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
Results
UV @ Start
% Peak
Step Yield
(%)
RP-HPLC
Purity (%)UV @ Start
Collection
Height End
Collection
(%) Purity (%)
Acceptance Criteria
≥ 45% ≥ 95%
0.4 10 53 95
0.5 20 56 97
0.5 20 50 97
0.4 30 59 96
0 5 20 51 970.5 20 51 97
0.6 30 53 97
0.6 10 52 96
0 6 30 40 970.6 30 40 97
0.6 10 50 98
0.4 10 45 97
0.5 20 51 970.5 20 51 97
0.4 30 60 97
Slide 9
Company Confidential
Statistical dat
• For evaluation of statisti
on protein quality and q
software package was u
Squares model for EffecSquares model for Effec
• The model was run sep
of yield and purity by RP
• The fractional factorial m
inclusion of all single fac
interactions as model efinteractions as model ef
resource and time const
was not possible.
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
ta analysis
ically significant effects of factors
uantity, the JMP statistical
used applying the Standard Least
ct Leveragect Leverage.
arately for two output parameters
P-HPLC.
model was initially run with the
ctor and some two-factor
ffects (Resolution IV) Due toffects (Resolution IV). Due to
traints, a higher resolution study
Slide 10
Company Confidential
Statistical Model P
Step Yieldp
• The final model used for
effects and two factor int
• There were two significa
i ifi t i t ti Tsignificant interaction. T
graphically represented i
plots and interaction conp
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
Parameter Estimates for
assessment all four primaryp y
teractions listed above.
nt main effects and one
h l ihese conclusions were
in the main effects leverage
tour plots.p
Slide 11
Company Confidential
Main Effect Lever
a. UV at Start Collection
c. Gradient Slope
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
rage Plots for Step Yield
b. UV at End Collection
d. Resin Load
Slide 12
Company Confidential
Statistical Model P
Purity by RP-HPLy y
• The final model used for
primary effects (excludin
two-factor interactionstwo factor interactions.
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
Parameter Estimates for
C
r assessment included all four
ng resin load) as well as three
Slide 13
Company Confidential
Two-Factor Intera
Purity by RP-HPLy y
Step Yield (%)
Gradient Slope (%/CV)
0
UV @ End (%)
a. UV at End Collection x Gradient Slope
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
action Contour Plots for
C
Step Yield (%)
Resin Load (g/L resin)
0
UV @ Start (AU)
b. UV at Start Collection x Gradient Slope
Slide 14
Company Confidential
Confirmation
• There is one area of th
represents process failp p
yield, run 8. In order to
acceptance criterion is
operated within its defioperated within its defi
modified and two addit
augment the initial des
• We chose to tighten th
as it was determined to
significant primary effesignificant primary effe
analysis.
• None of the experimenp
failed the acceptance c
confirms the predicted
study
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
study.
of Results
he tested design space that
lure space with regard to stepp g p
o ensure that the step yield
always met when the process is
ned PARs the design space wasned PARs, the design space was
tional runs were performed to
sign.
e gradient slope upper limit to 11%
o be easy to control and the most
ect for step yield in our initialect for step yield in our initial
ntal runs for the tightened limitsg
criterion for step yield. This
design space from the initial
Slide 15
Company Confidential
Design Space
SpaceSpace
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
e vs Defined Control
Based on the models generated for
h f th d fi deach of the defined process
outputs, a three-dimensional plot
was generated to graphically show
the process control space with
d h i llregard to the experimentally
defined design space
Slide 16
Company Confidential
Conclusions
• The results of this DO
design space from the
• Based on our findings
h f th thwe chose for the three
appropriate with the ex
• As a result we tighteneAs a result we tightene
• The IPC limits for resin
set appropriately.
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
E study confirm the predictedy p
e initial study.
we determined that the IPC limits
i t te input parameters were
xception of Gradient Slope.
ed our control limitsed our control limits.
n load were also determined to be
Slide 17
Company Confidential
Final Paramet
Normal Ope
Operating Parameter
Normal Ope
(NO
UV at the beginning of
pooling, % from peak max Target: >p g p
UV at the end of pooling, %
from peak max Targe
Gradient slope, % per CV TargeGradient slope, % per CV Targe
Performance Parameter In
Resin Load, g/L
* Note: The claimed experimentally confirmed range is slightly tighter than th
support the higher end of the range.
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
ter Limits
rating Range Experimentally Confirmedrating Range
OR)
Experimentally Confirmed
Ranges
> 0.5 AU 0.4 – 0.6 AU
t: 20% 10 – 30%
et: 8% 4 – 11%*et: 8% 4 11%
n-Process Acceptance Criterion
15 – 25 g/L
he design space in that it takes the worst-case data point to
Slide 18
Company Confidential
Thank You
BioTechLogic Inc serBioTechLogic Inc. ser
biopharmaceutical ind
with companies to mwith companies to m
resource and comme
TECH
LOGICBIO TECH
LOGICBIO ®BioTechLogic, Inc.
rves therves the
dustry by collaborating
eet their developmenteet their development,
ercialization needs.
www.biotechlogic.com
www.processvalidation.com
Slide 19
Company Confidential

Mais conteúdo relacionado

Semelhante a Applying QbD to Biotech Process Validation

BusinessAdministration2_02.pdf
BusinessAdministration2_02.pdfBusinessAdministration2_02.pdf
BusinessAdministration2_02.pdfSylvainSakwaDidy
 
Response Surface Regression
Response Surface RegressionResponse Surface Regression
Response Surface RegressionRonald Shewchuk
 
Fuel nano additive technology
Fuel  nano additive technologyFuel  nano additive technology
Fuel nano additive technologytabirsir
 
Isa saint-louis-exceptional-opportunities-short-course-day-2
Isa saint-louis-exceptional-opportunities-short-course-day-2Isa saint-louis-exceptional-opportunities-short-course-day-2
Isa saint-louis-exceptional-opportunities-short-course-day-2Jim Cahill
 
How to Setup and Adjust the Dynamic Compensation of Feedforward Signals
How to Setup and Adjust the Dynamic Compensation of Feedforward SignalsHow to Setup and Adjust the Dynamic Compensation of Feedforward Signals
How to Setup and Adjust the Dynamic Compensation of Feedforward SignalsJim Cahill
 
PID Control of True Integrating Processes - Greg McMillan Deminar
PID Control of True Integrating Processes - Greg McMillan DeminarPID Control of True Integrating Processes - Greg McMillan Deminar
PID Control of True Integrating Processes - Greg McMillan DeminarJim Cahill
 
22424roduction Slides 33623-1.ppt
22424roduction Slides 33623-1.ppt22424roduction Slides 33623-1.ppt
22424roduction Slides 33623-1.pptMuskanKhan320706
 
Industrial plant optimization in reduced dimensional spaces
Industrial plant optimization in reduced dimensional spacesIndustrial plant optimization in reduced dimensional spaces
Industrial plant optimization in reduced dimensional spacesCapstone
 
Process Validation Presentation from BioTechLogic
Process Validation Presentation from BioTechLogicProcess Validation Presentation from BioTechLogic
Process Validation Presentation from BioTechLogicPeter Dellva
 
Multivariate Linear Regression Model for Simulaneous Estimation of Debutanise...
Multivariate Linear Regression Model for Simulaneous Estimation of Debutanise...Multivariate Linear Regression Model for Simulaneous Estimation of Debutanise...
Multivariate Linear Regression Model for Simulaneous Estimation of Debutanise...NSEAkure
 
EUGM 2014 - Serge P. Parel (Exquiron): Farewell, PipelinePilot : Migrating th...
EUGM 2014 - Serge P. Parel (Exquiron): Farewell, PipelinePilot : Migrating th...EUGM 2014 - Serge P. Parel (Exquiron): Farewell, PipelinePilot : Migrating th...
EUGM 2014 - Serge P. Parel (Exquiron): Farewell, PipelinePilot : Migrating th...ChemAxon
 
Aspen Plus - Bootcamp - 12 Case Studies (1 of 2) (Slideshare)
Aspen Plus - Bootcamp - 12 Case Studies (1 of 2) (Slideshare)Aspen Plus - Bootcamp - 12 Case Studies (1 of 2) (Slideshare)
Aspen Plus - Bootcamp - 12 Case Studies (1 of 2) (Slideshare)Chemical Engineering Guy
 
Overview of Qiskit Ignis - Struggle with errors -
Overview of Qiskit Ignis   - Struggle with errors - Overview of Qiskit Ignis   - Struggle with errors -
Overview of Qiskit Ignis - Struggle with errors - Shin Nishio
 
PID Control of Valve Sticktion and Backlash - Greg McMillan Deminar Series
PID Control of Valve Sticktion and Backlash - Greg McMillan Deminar SeriesPID Control of Valve Sticktion and Backlash - Greg McMillan Deminar Series
PID Control of Valve Sticktion and Backlash - Greg McMillan Deminar SeriesJim Cahill
 
LG Display Medianav ECU Available in the Dacia Duster
LG Display Medianav ECU Available in the Dacia DusterLG Display Medianav ECU Available in the Dacia Duster
LG Display Medianav ECU Available in the Dacia Dustersystem_plus
 

Semelhante a Applying QbD to Biotech Process Validation (20)

Evolutionary Operation
Evolutionary OperationEvolutionary Operation
Evolutionary Operation
 
BusinessAdministration2_02.pdf
BusinessAdministration2_02.pdfBusinessAdministration2_02.pdf
BusinessAdministration2_02.pdf
 
Response Surface Regression
Response Surface RegressionResponse Surface Regression
Response Surface Regression
 
Fuel nano additive technology
Fuel  nano additive technologyFuel  nano additive technology
Fuel nano additive technology
 
Isa saint-louis-exceptional-opportunities-short-course-day-2
Isa saint-louis-exceptional-opportunities-short-course-day-2Isa saint-louis-exceptional-opportunities-short-course-day-2
Isa saint-louis-exceptional-opportunities-short-course-day-2
 
How to Setup and Adjust the Dynamic Compensation of Feedforward Signals
How to Setup and Adjust the Dynamic Compensation of Feedforward SignalsHow to Setup and Adjust the Dynamic Compensation of Feedforward Signals
How to Setup and Adjust the Dynamic Compensation of Feedforward Signals
 
PID Control of True Integrating Processes - Greg McMillan Deminar
PID Control of True Integrating Processes - Greg McMillan DeminarPID Control of True Integrating Processes - Greg McMillan Deminar
PID Control of True Integrating Processes - Greg McMillan Deminar
 
TQM
TQMTQM
TQM
 
22424roduction Slides 33623-1.ppt
22424roduction Slides 33623-1.ppt22424roduction Slides 33623-1.ppt
22424roduction Slides 33623-1.ppt
 
Polymer APC
Polymer APCPolymer APC
Polymer APC
 
Industrial plant optimization in reduced dimensional spaces
Industrial plant optimization in reduced dimensional spacesIndustrial plant optimization in reduced dimensional spaces
Industrial plant optimization in reduced dimensional spaces
 
Process Validation Presentation from BioTechLogic
Process Validation Presentation from BioTechLogicProcess Validation Presentation from BioTechLogic
Process Validation Presentation from BioTechLogic
 
Multivariate Linear Regression Model for Simulaneous Estimation of Debutanise...
Multivariate Linear Regression Model for Simulaneous Estimation of Debutanise...Multivariate Linear Regression Model for Simulaneous Estimation of Debutanise...
Multivariate Linear Regression Model for Simulaneous Estimation of Debutanise...
 
EUGM 2014 - Serge P. Parel (Exquiron): Farewell, PipelinePilot : Migrating th...
EUGM 2014 - Serge P. Parel (Exquiron): Farewell, PipelinePilot : Migrating th...EUGM 2014 - Serge P. Parel (Exquiron): Farewell, PipelinePilot : Migrating th...
EUGM 2014 - Serge P. Parel (Exquiron): Farewell, PipelinePilot : Migrating th...
 
Aspen Plus - Bootcamp - 12 Case Studies (1 of 2) (Slideshare)
Aspen Plus - Bootcamp - 12 Case Studies (1 of 2) (Slideshare)Aspen Plus - Bootcamp - 12 Case Studies (1 of 2) (Slideshare)
Aspen Plus - Bootcamp - 12 Case Studies (1 of 2) (Slideshare)
 
Overview of Qiskit Ignis - Struggle with errors -
Overview of Qiskit Ignis   - Struggle with errors - Overview of Qiskit Ignis   - Struggle with errors -
Overview of Qiskit Ignis - Struggle with errors -
 
PID Control of Valve Sticktion and Backlash - Greg McMillan Deminar Series
PID Control of Valve Sticktion and Backlash - Greg McMillan Deminar SeriesPID Control of Valve Sticktion and Backlash - Greg McMillan Deminar Series
PID Control of Valve Sticktion and Backlash - Greg McMillan Deminar Series
 
ch06.ppt
ch06.pptch06.ppt
ch06.ppt
 
Facility Location
Facility Location Facility Location
Facility Location
 
LG Display Medianav ECU Available in the Dacia Duster
LG Display Medianav ECU Available in the Dacia DusterLG Display Medianav ECU Available in the Dacia Duster
LG Display Medianav ECU Available in the Dacia Duster
 

Mais de Institute of Validation Technology

Incorporate Domestic and International Regulations for Effective GMP Auditing
Incorporate Domestic and International Regulations for Effective GMP AuditingIncorporate Domestic and International Regulations for Effective GMP Auditing
Incorporate Domestic and International Regulations for Effective GMP AuditingInstitute of Validation Technology
 
Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...Institute of Validation Technology
 
Computer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the CloudComputer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the CloudInstitute of Validation Technology
 
Management Strategies to Facilitate Continual Quality Improvement
Management Strategies to Facilitate Continual Quality ImprovementManagement Strategies to Facilitate Continual Quality Improvement
Management Strategies to Facilitate Continual Quality ImprovementInstitute of Validation Technology
 
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...Institute of Validation Technology
 
Designing Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical DevelopmentDesigning Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical DevelopmentInstitute of Validation Technology
 
Incorporate CPV and Continual Improvement into your Validation Plan
Incorporate CPV and Continual Improvement into your Validation PlanIncorporate CPV and Continual Improvement into your Validation Plan
Incorporate CPV and Continual Improvement into your Validation PlanInstitute of Validation Technology
 
Introduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process ValidationIntroduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process ValidationInstitute of Validation Technology
 
GMP Systems Integration–Combine Results and Utilize as a Compliance Tool
GMP Systems Integration–Combine Results and Utilize as a Compliance ToolGMP Systems Integration–Combine Results and Utilize as a Compliance Tool
GMP Systems Integration–Combine Results and Utilize as a Compliance ToolInstitute of Validation Technology
 

Mais de Institute of Validation Technology (20)

Incorporate Domestic and International Regulations for Effective GMP Auditing
Incorporate Domestic and International Regulations for Effective GMP AuditingIncorporate Domestic and International Regulations for Effective GMP Auditing
Incorporate Domestic and International Regulations for Effective GMP Auditing
 
Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...Notification Tactics for Improved Notification Tactics For Improved Field Act...
Notification Tactics for Improved Notification Tactics For Improved Field Act...
 
Lifecycle Approach to Cleaning Validation
Lifecycle Approach to Cleaning ValidationLifecycle Approach to Cleaning Validation
Lifecycle Approach to Cleaning Validation
 
Computer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the CloudComputer System Validation Then and Now — Learning Management in the Cloud
Computer System Validation Then and Now — Learning Management in the Cloud
 
Management Strategies to Facilitate Continual Quality Improvement
Management Strategies to Facilitate Continual Quality ImprovementManagement Strategies to Facilitate Continual Quality Improvement
Management Strategies to Facilitate Continual Quality Improvement
 
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
Understand the Evolving Regulations for Aseptic Cleaning and Environmental Mo...
 
Effective Use of Environmental Monitoring Data Trending
Effective Use of Environmental Monitoring Data TrendingEffective Use of Environmental Monitoring Data Trending
Effective Use of Environmental Monitoring Data Trending
 
Mock Inspection Case Studies
Mock Inspection Case StudiesMock Inspection Case Studies
Mock Inspection Case Studies
 
Validation Master Plan
Validation Master PlanValidation Master Plan
Validation Master Plan
 
Designing Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical DevelopmentDesigning Stability Studies for Early Stages of Pharmaceutical Development
Designing Stability Studies for Early Stages of Pharmaceutical Development
 
Determine Exceptions to Validation
Determine Exceptions to ValidationDetermine Exceptions to Validation
Determine Exceptions to Validation
 
Conduct a Gap Analysis of a Validation Programme
Conduct a Gap Analysis of a Validation ProgrammeConduct a Gap Analysis of a Validation Programme
Conduct a Gap Analysis of a Validation Programme
 
FDA Inspection
FDA InspectionFDA Inspection
FDA Inspection
 
Incorporate CPV and Continual Improvement into your Validation Plan
Incorporate CPV and Continual Improvement into your Validation PlanIncorporate CPV and Continual Improvement into your Validation Plan
Incorporate CPV and Continual Improvement into your Validation Plan
 
Compliance by Design and Compliance Master Plan
Compliance by Design and Compliance Master PlanCompliance by Design and Compliance Master Plan
Compliance by Design and Compliance Master Plan
 
Introduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process ValidationIntroduction to Statistical Applications for Process Validation
Introduction to Statistical Applications for Process Validation
 
Risk-Based Approaches in GMP’s Project Life Cycles
Risk-Based Approaches in GMP’s Project Life CyclesRisk-Based Approaches in GMP’s Project Life Cycles
Risk-Based Approaches in GMP’s Project Life Cycles
 
GMP Systems Integration–Combine Results and Utilize as a Compliance Tool
GMP Systems Integration–Combine Results and Utilize as a Compliance ToolGMP Systems Integration–Combine Results and Utilize as a Compliance Tool
GMP Systems Integration–Combine Results and Utilize as a Compliance Tool
 
A Lifecycle Approach to Process Validation
A Lifecycle Approach to Process ValidationA Lifecycle Approach to Process Validation
A Lifecycle Approach to Process Validation
 
Setting Biological Process Specifications
Setting Biological Process SpecificationsSetting Biological Process Specifications
Setting Biological Process Specifications
 

Último

Developer Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLDeveloper Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLScyllaDB
 
How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.Curtis Poe
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubKalema Edgar
 
The State of Passkeys with FIDO Alliance.pptx
The State of Passkeys with FIDO Alliance.pptxThe State of Passkeys with FIDO Alliance.pptx
The State of Passkeys with FIDO Alliance.pptxLoriGlavin3
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsRizwan Syed
 
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptxUse of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptxLoriGlavin3
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Mark Simos
 
Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Commit University
 
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxDigital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxLoriGlavin3
 
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdfHyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdfPrecisely
 
Unraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfUnraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfAlex Barbosa Coqueiro
 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brandgvaughan
 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek SchlawackFwdays
 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024Lorenzo Miniero
 
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxMerck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxLoriGlavin3
 
From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .Alan Dix
 
The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptx
The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptxThe Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptx
The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptxLoriGlavin3
 
Generative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersGenerative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersRaghuram Pandurangan
 
"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr BaganFwdays
 

Último (20)

Developer Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQLDeveloper Data Modeling Mistakes: From Postgres to NoSQL
Developer Data Modeling Mistakes: From Postgres to NoSQL
 
How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.How AI, OpenAI, and ChatGPT impact business and software.
How AI, OpenAI, and ChatGPT impact business and software.
 
Unleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding ClubUnleash Your Potential - Namagunga Girls Coding Club
Unleash Your Potential - Namagunga Girls Coding Club
 
The State of Passkeys with FIDO Alliance.pptx
The State of Passkeys with FIDO Alliance.pptxThe State of Passkeys with FIDO Alliance.pptx
The State of Passkeys with FIDO Alliance.pptx
 
Scanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL CertsScanning the Internet for External Cloud Exposures via SSL Certs
Scanning the Internet for External Cloud Exposures via SSL Certs
 
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptxUse of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
Use of FIDO in the Payments and Identity Landscape: FIDO Paris Seminar.pptx
 
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
Tampa BSides - Chef's Tour of Microsoft Security Adoption Framework (SAF)
 
Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!Nell’iperspazio con Rocket: il Framework Web di Rust!
Nell’iperspazio con Rocket: il Framework Web di Rust!
 
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptxDigital Identity is Under Attack: FIDO Paris Seminar.pptx
Digital Identity is Under Attack: FIDO Paris Seminar.pptx
 
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdfHyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
Hyperautomation and AI/ML: A Strategy for Digital Transformation Success.pdf
 
Unraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdfUnraveling Multimodality with Large Language Models.pdf
Unraveling Multimodality with Large Language Models.pdf
 
WordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your BrandWordPress Websites for Engineers: Elevate Your Brand
WordPress Websites for Engineers: Elevate Your Brand
 
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
"Subclassing and Composition – A Pythonic Tour of Trade-Offs", Hynek Schlawack
 
SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024SIP trunking in Janus @ Kamailio World 2024
SIP trunking in Janus @ Kamailio World 2024
 
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptxMerck Moving Beyond Passwords: FIDO Paris Seminar.pptx
Merck Moving Beyond Passwords: FIDO Paris Seminar.pptx
 
From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .From Family Reminiscence to Scholarly Archive .
From Family Reminiscence to Scholarly Archive .
 
The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptx
The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptxThe Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptx
The Role of FIDO in a Cyber Secure Netherlands: FIDO Paris Seminar.pptx
 
Generative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information DevelopersGenerative AI for Technical Writer or Information Developers
Generative AI for Technical Writer or Information Developers
 
DMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special EditionDMCC Future of Trade Web3 - Special Edition
DMCC Future of Trade Web3 - Special Edition
 
"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan"ML in Production",Oleksandr Bagan
"ML in Production",Oleksandr Bagan
 

Applying QbD to Biotech Process Validation

  • 1. BIBioTech BI Applying Validation A case stu Stage 1 – TECH LOGIC BioTechLogic, Inc. BIO TECH LOGICBIO ® TECH IOLOGIC Logic, Inc. IO ® g QbD to Biotech Process n : udy in applying QbD to – Process Design IVT Validation Week 28-30 March 201128 30 March 2011 Kurtis Epp, John Kandl BioTechLogic, Inc.
  • 2. Agenda • Process Backgrou • Risk Assessment • DOE • Parameter Evaluat • Conclusions TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. und tion Slide 2 Company Confidential
  • 3. Process Back The scope of this case stup data obtained from small- Chromatography runs per limits in experiments planlimits in experiments plan Design of Experiments (D TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. kground udy is to provide and evaluatey p -scale Ion Exchange rformed within defined parameter ned and executed according toned and executed according to DOE). Slide 3 Company Confidential
  • 4. Process Back TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. kground Slide 4 Company Confidential
  • 5. Risk Assessm Operating Parameter Normal Operating UV at Start of AEX Fraction Collection > 0.50 AU UV at End of AEX Fraction Collection < 20% of maximum p Elution Gradient 8% per CV Elution Gradient (20 – 100% B ove Equilibration volume ≥ 5 CV Load flow rate 100 – 120 L/h (Targe Wash flow rate 100 – 120 L/h (Targe Elution flow rate 100 – 120 L/h (Targe Pre-Equilibration flow rate 100 – 120 L/h (Targe F1 F3: 0 2 Fraction Volume F1 – F3: 0.2 F4+: 0.1 CV Wash volume ≥2 CV Fraction Mixing Speed 65 rpm Fraction Mixing Time 20 - 30 min Pool Mixing Time 10 – 15 min Pool Mixing Time Pool Mixing Speed 100 rpm Pre-Equilibration volume ≥ 4 CV WFI Rinse volume ≥ 3 CV WFI Rinse flow rate 100 – 120 L/h (Targe Equilibration flow rate 100 – 120 L/h (Targeq ( g In-Process Control Limits Column Load 15 – 25 g / L r Column Bed Height 30 ± 3 cm Column Backpressure during Equilibration, Load, Wash, and Elution < 3 bar Effl t H t d f E ilib ti ± 0.3 pH Units of Eq Effluent pH at end of Equilibration p q Buffer pH Effluent Cond. at end of Equilibration ± 1 mS/cm Units of E Buffer Conduc Effluent UV at the end of Equilibration Zero Fraction Pooling Criteria (RP-HPLC) ≥ 95% Main P TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. ment g Range Potential Effect(s) of Failure SEV OCC DET RPN U Product loss, quality 9 4 2 72 peak height Product loss, quality 9 4 2 72 V Inconsistent quality 8 2 4 64 r 10 CV) Inconsistent quality 8 2 4 64 Product loss, quality 9 2 1 18 et: 110 L/h) Inconsistent quality 4 1 3 12 et: 110 L/h) Inconsistent quality 4 1 3 12 et: 110 L/h) Inconsistent quality 4 1 3 12 et: 110 L/h) Longer equilibration 4 1 3 12 CVCV V Product loss, quality 9 1 1 9 Inconsistent quality 5 1 1 5 Inconsistent quality 4 1 1 4 n Inconsistent quality 4 1 1 4 n Non-homogeneity, inconsistent sampling/yield 4 1 1 4 sampling/yield Non-homogeneity, inconsistent sampling/yield 4 1 1 4 Longer equilibration 3 1 1 3 Longer equilibration 3 1 1 3 et: 110 L/h) Longer equilibration 1 1 1 3 et: 110 L/h) Product loss, quality 3 1 1 3) , q y resin m quilibrationq Equilibration ctivity Peak Slide 5 Company Confidential
  • 6. Risk Assessm The parameters selectedp the UV at start of fraction collection, gradient slope D d t i blDependent variables ana and purity by RP-HPLC. Testin Input parameter Lower UV at the beginning of fraction collection (AU) 0.40 UV at the end of pooling (% from peak max) 10 Gradient slope (% per CV) 4.0 Resin Load, (g/L resin) 15 TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. ment d for evaluation in this study werey n collection, UV at end of fraction e, and resin load. l d t i i ldalyzed were protein recovery yield ng limitsg Output parameters Upper 0.60 Purity by RP-HPLC (≥ 95%) Step yield (≥ 75%) 30 12.0 25 Slide 6 Company Confidential
  • 7. DOE Pattern Exp. No.: UV at the sta of fraction collection p collection (AU) −−−− 1 0.4 0000 2 0.5 0000 3 0 50000 3 0.5 −++− 4 0.4 0000 5 0.5 ++−− 6 0.6 7 0 6+−−+ 7 0.6 ++++ 8 0.6 +−+− 9 0.6 −−++ 10 0.4 0000 11 0.5 −+−+ 12 0.4 Note: It is important to randomize independence of your observation mistake by the operator. TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. art n UV at the end of pooling Gradient slope Resin Load (g/L) (% peak max) (% per CV) (g/L) 10 4 15 20 8 20 20 8 2020 8 20 30 12 15 20 8 20 30 4 15 10 4 2510 4 25 30 12 25 10 12 15 10 12 25 20 8 20 30 4 25 e the run order to assure the ns and reduce the chances of a Slide 7 Company Confidential
  • 8. Experimental • A summary of the var Ion Exchange Chrom Outputs step yield anOutputs, step yield an listed in the following • Runs that did not mee are shaded to indicate TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. Results riable parameters for each of the atography runs as well as the nd eluate purity by RP HPLC arend eluate purity by RP-HPLC are table. et the defined acceptance criteriap e run failure Slide 8 Company Confidential
  • 9. Experimental Run Resin Load GradientRun Number Resin Load (g/L) Gradient Slope (%) 1 15 4 2 20 8 3 20 8 4 15 12 5 20 85 20 8 6 15 4 7 25 4 8 25 128 25 12 9 15 12 10 25 12 11 20 811 20 8 12 25 4 TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. Results UV @ Start % Peak Step Yield (%) RP-HPLC Purity (%)UV @ Start Collection Height End Collection (%) Purity (%) Acceptance Criteria ≥ 45% ≥ 95% 0.4 10 53 95 0.5 20 56 97 0.5 20 50 97 0.4 30 59 96 0 5 20 51 970.5 20 51 97 0.6 30 53 97 0.6 10 52 96 0 6 30 40 970.6 30 40 97 0.6 10 50 98 0.4 10 45 97 0.5 20 51 970.5 20 51 97 0.4 30 60 97 Slide 9 Company Confidential
  • 10. Statistical dat • For evaluation of statisti on protein quality and q software package was u Squares model for EffecSquares model for Effec • The model was run sep of yield and purity by RP • The fractional factorial m inclusion of all single fac interactions as model efinteractions as model ef resource and time const was not possible. TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. ta analysis ically significant effects of factors uantity, the JMP statistical used applying the Standard Least ct Leveragect Leverage. arately for two output parameters P-HPLC. model was initially run with the ctor and some two-factor ffects (Resolution IV) Due toffects (Resolution IV). Due to traints, a higher resolution study Slide 10 Company Confidential
  • 11. Statistical Model P Step Yieldp • The final model used for effects and two factor int • There were two significa i ifi t i t ti Tsignificant interaction. T graphically represented i plots and interaction conp TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. Parameter Estimates for assessment all four primaryp y teractions listed above. nt main effects and one h l ihese conclusions were in the main effects leverage tour plots.p Slide 11 Company Confidential
  • 12. Main Effect Lever a. UV at Start Collection c. Gradient Slope TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. rage Plots for Step Yield b. UV at End Collection d. Resin Load Slide 12 Company Confidential
  • 13. Statistical Model P Purity by RP-HPLy y • The final model used for primary effects (excludin two-factor interactionstwo factor interactions. TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. Parameter Estimates for C r assessment included all four ng resin load) as well as three Slide 13 Company Confidential
  • 14. Two-Factor Intera Purity by RP-HPLy y Step Yield (%) Gradient Slope (%/CV) 0 UV @ End (%) a. UV at End Collection x Gradient Slope TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. action Contour Plots for C Step Yield (%) Resin Load (g/L resin) 0 UV @ Start (AU) b. UV at Start Collection x Gradient Slope Slide 14 Company Confidential
  • 15. Confirmation • There is one area of th represents process failp p yield, run 8. In order to acceptance criterion is operated within its defioperated within its defi modified and two addit augment the initial des • We chose to tighten th as it was determined to significant primary effesignificant primary effe analysis. • None of the experimenp failed the acceptance c confirms the predicted study TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. study. of Results he tested design space that lure space with regard to stepp g p o ensure that the step yield always met when the process is ned PARs the design space wasned PARs, the design space was tional runs were performed to sign. e gradient slope upper limit to 11% o be easy to control and the most ect for step yield in our initialect for step yield in our initial ntal runs for the tightened limitsg criterion for step yield. This design space from the initial Slide 15 Company Confidential
  • 16. Design Space SpaceSpace TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. e vs Defined Control Based on the models generated for h f th d fi deach of the defined process outputs, a three-dimensional plot was generated to graphically show the process control space with d h i llregard to the experimentally defined design space Slide 16 Company Confidential
  • 17. Conclusions • The results of this DO design space from the • Based on our findings h f th thwe chose for the three appropriate with the ex • As a result we tighteneAs a result we tightene • The IPC limits for resin set appropriately. TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. E study confirm the predictedy p e initial study. we determined that the IPC limits i t te input parameters were xception of Gradient Slope. ed our control limitsed our control limits. n load were also determined to be Slide 17 Company Confidential
  • 18. Final Paramet Normal Ope Operating Parameter Normal Ope (NO UV at the beginning of pooling, % from peak max Target: >p g p UV at the end of pooling, % from peak max Targe Gradient slope, % per CV TargeGradient slope, % per CV Targe Performance Parameter In Resin Load, g/L * Note: The claimed experimentally confirmed range is slightly tighter than th support the higher end of the range. TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. ter Limits rating Range Experimentally Confirmedrating Range OR) Experimentally Confirmed Ranges > 0.5 AU 0.4 – 0.6 AU t: 20% 10 – 30% et: 8% 4 – 11%*et: 8% 4 11% n-Process Acceptance Criterion 15 – 25 g/L he design space in that it takes the worst-case data point to Slide 18 Company Confidential
  • 19. Thank You BioTechLogic Inc serBioTechLogic Inc. ser biopharmaceutical ind with companies to mwith companies to m resource and comme TECH LOGICBIO TECH LOGICBIO ®BioTechLogic, Inc. rves therves the dustry by collaborating eet their developmenteet their development, ercialization needs. www.biotechlogic.com www.processvalidation.com Slide 19 Company Confidential